Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 5/20 | 0.76 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.76 |
| ▸ | NR3C1 | P04150 | 13/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | TNF | P01375 | 1/20 | 0.74 |
| ▸ | IL6 | P05231 | 1/20 | 0.74 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.74 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.74 |
| ▸ | AR | P10275 | 1/20 | 0.74 |
| ▸ | GLUL | P15104 | 1/20 | 0.74 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.74 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.72 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23974880 | 1.00 | PGR (0.76) | PGRHIF1ANR3C1HSD17B10ABCB11 | |
| SCHEMBL1685716 | 0.92 | PGR (0.77) | PGRHIF1ANR3C1HSD17B10ABCB11 | |
| SCHEMBL5098424 | 0.92 | PGR (0.77) | PGRHIF1ANR3C1HSD17B10ABCB11 | |
| SCHEMBL12969465 | 0.89 | NR3C1 (0.76) | PGRHIF1ANR3C1HSD17B10ABCB11 | |
| SCHEMBL12738238 | 0.89 | NR3C1 (0.76) | PGRHIF1ANR3C1HSD17B10ABCB11 | |
| SCHEMBL1685803 | 0.89 | NR3C1 (0.76) | PGRHIF1ANR3C1HSD17B10ABCB11 | |
| SCHEMBL13379819 | 0.89 | NR3C1 (0.76) | PGRHIF1ANR3C1HSD17B10ABCB11 | |
| SCHEMBL15796471 | 0.89 | NR3C1 (0.76) | PGRHIF1ANR3C1HSD17B10ABCB11 | |
| SCHEMBL5098329 | 0.89 | NR3C1 (0.76) | PGRHIF1ANR3C1HSD17B10ABCB11 | |
| SCHEMBL11856593 | 0.88 | NR3C1 (0.84) | PGRHIF1ANR3C1HSD17B10ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8117 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137657-A1 | METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS | SPARROW PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260137558-A1 | OPHTHALMIC DEVICE | Able Tx Ltd. (IL) | 2026-05-21 | — | — | US | claimed |
| US-20260137656-A1 | METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS | SPARROW PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-12616654-B2 | Stainless steel can for pressurised metered dose inhalers | CHIESI FARMACEUTICI S.P.A. (IT) | 2026-05-05 | — | — | US | claimed |
| US-20260108610-A1 | Drug-Resistant Immune Cells and Methods of Use Thereof | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2026-04-23 | — | — | US | claimed |
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-12599556-B2 | Ophthalmic compositions | BIOTHERAVISION INC. (US) | 2026-04-14 | — | — | US | claimed |
| US-20260091017-A1 | TREATMENTS FOR INFLAMMATION | AUCKLAND UNISERVICES LTD (NZ) | 2026-04-02 | — | — | US | claimed |
| EP-4259102-B1 | COMPOSITIONS AND METHODS FOR MUCOSAL DRUG DELIVERY | UNIV CALIFORNIA (US) | 2026-03-11 | — | — | EP | claimed |
| CN-1315852-A | Medicinal aerosol formulations | JAGO RES AG (CH) | 2001-10-03 | — | — | CN | claimed |
| EP-1131059-A1 | DRY POWDER FOR INHALATION | JAGO RESEARCH AG (CH) | 2001-09-12 | — | — | EP | claimed |
| WO-2001058438-A1 | OPHTHALMIC USE OF ALPHA ADRENERGIC BLOCKING AGENTS | GALIN MILES A (US) | 2001-08-16 | — | — | WO | claimed |
| EP-1102579-A1 | MEDICINAL AEROSOL FORMULATIONS | JAGO RESEARCH AG (CH) | 2001-05-30 | — | — | EP | claimed |
| WO-2001022955-A2 | NOVEL COMBINATION OF LOTEPREDNOL AND ANTIHISTAMINES | VIATRIS GMBH & CO. KG (DE) | 2001-04-05 | — | — | WO | claimed |
| US-6106819-A | Methods of treating headache and functional extraocular and intraocular myotendinitis | SUCHER DAVID F (US) | 2000-08-22 | — | — | US | claimed |
| EP-1014943-A1 | MEDICAL AEROSOL FORMULATIONS | Jago Research AG (CH) | 2000-07-05 | — | — | EP | claimed |
| WO-2000028979-A1 | DRY POWDER FOR INHALATION | JAGO RESEARCH AG (CH) | 2000-05-25 | — | — | WO | claimed |
| WO-2000007567-A1 | MEDICINAL AEROSOL FORMULATIONS | JAGO RESEARCH AG (CH) | 2000-02-17 | — | — | WO | claimed |
| WO-1998034595-A1 | MEDICAL AEROSOL FORMULATIONS | JAGO RESEARCH AG (CH) | 1998-08-13 | — | — | WO | claimed |